v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Beginning balance, value at Dec. 31, 2024 $ 17,610 $ 6 $ 139,480 $ 48 $ (121,924)
Beginning balance (in shares) at Dec. 31, 2024   59,235,000      
Issuance of common stock in connection with the Sales Agreement, net of issuance costs (28)   (28)    
Issuance of common stock in connection with the Sales Agreement, net of issuance costs (in shares)   9,000      
Stock-based compensation expense 350   350    
Foreign currency translation adjustments (6)     (6)  
Net loss (6,302)       (6,302)
Ending balance, value at Mar. 31, 2025 11,624 $ 6 139,802 42 (128,226)
Ending balance (in shares) at Mar. 31, 2025   59,244,000      
Beginning balance, value at Dec. 31, 2024 17,610 $ 6 139,480 48 (121,924)
Beginning balance (in shares) at Dec. 31, 2024   59,235,000      
Issuance of common stock in connection with the Sales Agreement, net of issuance costs    
Stock-based compensation expense    
Foreign currency translation adjustments    
Net loss (19,976)  
Ending balance, value at Sep. 30, 2025 1,309 $ 6 143,062 141 (141,900)
Ending balance (in shares) at Sep. 30, 2025   61,511,000      
Beginning balance, value at Mar. 31, 2025 11,624 $ 6 139,802 42 (128,226)
Beginning balance (in shares) at Mar. 31, 2025   59,244,000      
Stock-based compensation expense 391   391    
Foreign currency translation adjustments 39     39  
Net loss (7,144)       (7,144)
Ending balance, value at Jun. 30, 2025 4,910 $ 6 140,193 81 (135,370)
Ending balance (in shares) at Jun. 30, 2025   59,244,000      
Issuance of common stock in connection with the Sales Agreement, net of issuance costs 2,593   2,593    
Issuance of common stock in connection with the Sales Agreement, net of issuance costs (in shares)   2,267,000      
Stock-based compensation expense 276 276
Foreign currency translation adjustments 60 60
Net loss (6,530) (6,530)
Ending balance, value at Sep. 30, 2025 1,309 $ 6 143,062 141 (141,900)
Ending balance (in shares) at Sep. 30, 2025   61,511,000      
Beginning balance, value at Dec. 31, 2025 $ 15,730 $ 8 164,225 30 (148,533)
Beginning balance (in shares) at Dec. 31, 2025 76,428,000 76,428,000      
Issuance of common stock to related party in connection with 2025 Private Sales Transactions $ 5,650   5,650    
Issuance of common stock to related party in connection with 2025 Private Sales Transactions (in shares)   5,179,000      
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs 2,174   2,174    
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs (in shares)   1,689,000      
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs 1,997   1,997    
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs (in shares)   1,351,000      
Stock-based compensation expense 312   312    
Foreign currency translation adjustments 2   2
Net loss (6,780)       (6,780)
Ending balance, value at Mar. 31, 2026 19,085 $ 8 174,358 32 (155,313)
Ending balance (in shares) at Mar. 31, 2026   84,647,000      
Beginning balance, value at Dec. 31, 2025 $ 15,730 $ 8 164,225 30 (148,533)
Beginning balance (in shares) at Dec. 31, 2025 76,428,000 76,428,000      
Issuance of common stock to related party in connection with 2025 Private Sales Transactions    
Issuance of common stock to related party in connection with 2026 Registered Direct Offering, net of issuance costs    
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs    
Stock-based compensation expense    
Foreign currency translation adjustments        
Net loss $ (20,400)  
Ending balance, value at Sep. 30, 2026 $ 13,218 $ 9 182,110 32 (168,933)
Ending balance (in shares) at Sep. 30, 2026 76,428,000 90,300,230      
Beginning balance, value at Mar. 31, 2026 $ 19,085 $ 8 174,358 32 (155,313)
Beginning balance (in shares) at Mar. 31, 2026   84,647,000      
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs 5,939 $ 1 5,938    
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs (in shares)   4,763,000      
Stock-based compensation expense 313   313    
Net loss (6,370)       (6,370)
Ending balance, value at Jun. 30, 2026 $ 18,967 $ 9 180,609 32 (161,683)
Ending balance (in shares) at Jun. 30, 2026 89,410        
Issuance of common stock to related party in connection with 2025 Private Sales Transactions $ 1,000 1,000
Issuance of common stock to related party in connection with 2025 Private Sales Transactions (in shares)   793,000      
Issuance of common stock to related party in connection with 2026 Private Placement, net of issuance costs        
Exercise of stock options 123 123
Exercise of stock options (in shares)   97,000      
Stock-based compensation expense 378 378
Net loss (7,250)   (7,250)
Ending balance, value at Sep. 30, 2026 $ 13,218 $ 9 $ 182,110 $ 32 $ (168,933)
Ending balance (in shares) at Sep. 30, 2026 76,428,000 90,300,230